Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valentior - colecalciferol,cyanocobalamin,folic acid,inositol,nicotinamide,pyridoxine hydrochloride -

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valentior - ascorbic acid,betacarotene,biotin,calcium folinate,calcium hydrogen phosphate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,concentrated fish omega-3 triglycerides,cupric sulfate,cyanocobalamin,d-alpha-tocopherol,ferrous fumarate,folic acid,heavy magnesium oxide,manganese gluconate,nicotinamide,phytomenadione,potassium iodide,pyridoxine hydrochloride,riboflavine,selenomethionine,thiamine nitrate,zinc citrate dihydrate -

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valentior - calcium folinate, quantity: 127 microgram (equivalent: folinic acid, qty 100 microgram); d-alpha-tocopherol, quantity: 6.71 mg (equivalent: d-alpha-tocopherol, qty 10 iu); heavy magnesium oxide, quantity: 49.8 mg (equivalent: magnesium, qty 30 mg); pyridoxine hydrochloride, quantity: 3 mg (equivalent: pyridoxine, qty 2.47 mg); zinc citrate dihydrate, quantity: 31.1 mg (equivalent: zinc, qty 10 mg); nicotinamide, quantity: 18 mg; phytomenadione, quantity: 60 microgram; calcium hydrogen phosphate, quantity: 170 mg (equivalent: calcium, qty 50 mg; equivalent: phosphorus, qty 38.7 mg); riboflavine, quantity: 1.8 mg; thiamine nitrate, quantity: 1.6 mg; selenomethionine, quantity: 75 microgram (equivalent: selenium, qty 30 microgram); potassium iodide, quantity: 328 microgram (equivalent: iodine, qty 250 microgram); cupric sulfate, quantity: 2.52 mg (equivalent: copper, qty 1 mg); chromium picolinate, quantity: 202 microgram (equivalent: chromium, qty 25 microgram); choline bitartrate, quantity: 20 mg; ascorbic acid, quantity: 50 mg; concentrated fish omega-3 triglycerides, quantity: 500 mg (equivalent: docosahexaenoic acid, qty 250 mg; equivalent: eicosapentaenoic acid, qty 50 mg); biotin, quantity: 200 microgram; ferrous fumarate, quantity: 75.4 mg (equivalent: iron, qty 24 mg); manganese gluconate, quantity: 8.77 mg (equivalent: manganese, qty 1 mg); folic acid, quantity: 400 microgram; calcium pantothenate, quantity: 7.63 mg (equivalent: pantothenic acid, qty 7 mg); cyanocobalamin, quantity: 0.01 mg; colecalciferol, quantity: 10 microgram; betacarotene, quantity: 3 mg - capsule, soft - excipient ingredients: silicon dioxide; mixed (low-alpha type) tocopherols concentrate; soya oil; yellow beeswax; gelatin; hydrogenated vegetable oil; purified water; lecithin; iron oxide red; glycerol; titanium dioxide; mannitol; vegetable oil; dl-alpha-tocopherol; maize oil; colour - antioxidant/reduce free radicals formed in the body ; helps enhance/promote healthy growth and development ; maintain/support general health and wellbeing ; maintain/support red blood cell health ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral) within normal range ; maintain/support female reproductive system health ; maintains/support healthy foetal development ; maintain/support healthy pregnancy ; help to prevent neural tube defects such as spina bifida and/or anencephaly ; maintain/support preconception health ; helps enhance/promote maternal postnatal health ; helps prepare the body for pregnancy ; maintain/support skin health

Європейський Союз - англійська - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - prostatic neoplasms - endocrine therapy - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer.- for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.- as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Європейський Союз - англійська - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - atosiban (as acetate) - premature birth - other gynecologicals - tractotile is indicated to delay imminent pre-term birth in pregnant adult women with:regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes;a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%;a gestational age from 24 until 33 completed weeks;a normal foetal heart rate.

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml